| Q92894168 | Auditory synaptopathy, auditory neuropathy, and cochlear implantation |
| Q90220788 | Cochlear Implantation in Children with Usher's Syndrome: A South Asian Experience |
| Q34127071 | Cochlear implantation in common forms of genetic deafness |
| Q35830124 | Current understanding of usher syndrome type II. |
| Q37727784 | Genetics and pathological mechanisms of Usher syndrome |
| Q30405367 | Identifying Children With Poor Cochlear Implantation Outcomes Using Massively Parallel Sequencing |
| Q40102428 | In vitro and ex vivo suppression by aminoglycosides of PCDH15 nonsense mutations underlying type 1 Usher syndrome |
| Q50357437 | Influence of etiologic factors on speech perception of cochlear-implanted children |
| Q57153042 | Knockout of ush2a gene in zebrafish causes hearing impairment and late onset rod-cone dystrophy |
| Q49500850 | Outcomes and benefits of pediatric cochlear implantation in children with additional disabilities: a review and report of family influences on outcomes |
| Q30448632 | Prediction of cochlear implant performance by genetic mutation: the spiral ganglion hypothesis |
| Q39203615 | Surgical aspects of cochlear implantation in syndromic children |
| Q36761749 | The changing face of Usher syndrome: clinical implications |
| Q50444600 | Usher syndrome: clinical features, diagnostic options, and therapeutic prospects |